logo

Aakaar Medical Technologies IPO

₹1,08,800/1600 shares

Minimum Investment

IPO Details

Open Date

20 Jun 25

Close Date

24 Jun 25

Minimum Investment

1,08,800

Lot Size

1600

Price Range

68 to ₹72

Listing Exchange

NSE

Issue Size

27 Cr

Listing Date

27 Jun 25

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Aakaar Medical Technologies IPO Timeline

Bidding Start

20 Jun 25

Bidding Ends

24 Jun 25

Allotment Finalisation

25 Jun 25

Refund Initiation

26 Jun 25

Demat Transfer

26 Jun 25

Listing

27 Jun 25

Aakaar Medical Technologies Limited

The company specialises in providing advanced products for dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. Its portfolio features both in-house brands—manufactured in India and abroad—and imported products from countries like South Korea, Spain, Italy, and Austria. These offerings are supplied to medical professionals, who either retail them to clients or use them during treatments. The product range includes homecare and professional skincare, injectable and contouring items, hair growth solutions, medifacial kits, laser and transplant devices, and machines for skin rejuvenation. With branches across India and 90 trained engineers, it serves customers in over 15 states.

Aakaar Medical Technologies Limited IPO Overview

Aakaar Medical Technologies is launching its IPO through a book-building issue worth ₹27.00 crores, comprising a fresh issue of 37.50 lakh shares. The subscription window for the IPO opens on June 20, 2025, and will close on June 24, 2025. The basis of allotment is likely to be finalised on June 25, 2025, with the shares expected to list on NSE SME on June 27, 2025. The IPO price band is set at ₹68 to ₹72 per share. Retail investors must apply for a minimum lot of 1600 shares, requiring an investment of ₹1,08,800, though bidding at the cut-off price—around ₹1,15,200—is advisable due to anticipated oversubscription. For HNIs, the minimum investment is two lots, i.e., 3,200 shares, amounting to ₹2,30,400. Indorient Financial Services Ltd is the book-running lead manager, Bigshare Services Pvt Ltd is the registrar, and Alacrity Securities Ltd serves as the market maker for this IPO.

Aakaar Medical Technologies Limited IPO Details

Particulars Details
IPO Date 20 June 2025 to 24 June 2025
Listing Date 27 June 2025
Face Value ₹10 per share
Issue Price Band ₹68 to ₹72 per share
Lot Size  1600 Shares
Total Issue Size 37,50,400 shares (aggregating up to ₹27.00 Cr)
Fresh Issue 37,50,400 shares (aggregating up to ₹27.00 Cr)
Offer for Sale NA
Issue Type Bookbuilding IPO
Listing At NSE SME
Share Holding Pre Issue 1,04,22,416 shares
Share Holding Post Issue 1,41,72,816 shares
Market Maker Portion 1,88,800 shares

Aakaar Medical Technologies Limited IPO Reservation

Investor Category Shares Offered
QIB Not more than 50% of the Net Issue
Retail Not less than 35% of the Net Issue
NII (HNI) Not less than 15% of the Net Issue

 

Aakaar Medical Technologies Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 ₹1,15,200
Retail (Max) 1 1600 ₹1,15,200
HNI (Min) 2 3200 ₹2,30,400

Aakaar Medical Technologies Limited IPO Promoter Holding

Shareholding Status Percentage
Pre-Issue 91.11%
Post-Issue

Aakaar Medical Technologies Limited IPO Valuation Overview

KPI Value
Earnings Per Share (EPS) 6.13
Price/Earnings (P/E) Ratio TBD
Return on Net Worth (RoNW) 33.81%
Net Asset Value (NAV) 22.26
Return on Equity 33.81%
Return on Capital Employed (ROCE) 21.02%
EBITDA Margin 15.81%
PAT Margin 9.81%
Debt to Equity Ratio 0.98

Objectives of the Proceeds

  • Funding working capital requirement of the company, ₹2035 lakhs
  • Meet general corporate expenses

Key Financials (in ₹ lakhs)

Particulars 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 5410.44 3400.89 2322.87
Revenue 6158.28 4611.10 3278.46
Profit After Tax 603.95 287.02 215.32
Reserves and Surplus 1278.04 1184.16 896.07
Total Borrowings 2273.83 1505.66 587.43

SWOT Analysis of Aakaar Medical Technologies IPO

Strength and Opportunities

  • Over 11 years of aesthetic industry expertise.
  • Wide product range: devices, homecare, injectables.
  • Pioneer in bringing lasers, threadlifts to India.
  • FDAtrial success for Saypha® opens US expansion.

Risks and Threats

  • Limited consumer brand visibility beyond clinics.
  • Intense competition from global aesthetic tech firms.
  • Regulatory hurdles for new launches (e.g., FDA).
  • Reliance on thirdparty technology partners.

Explore IPO Opportunities

Explore our comprehensive IPO pages to stay updated on the latest trends and insights.

About Aakaar Medical Technologies Limited

Aakaar Medical Technologies Limited IPO Highlights

Aakaar Medical Technologies IPO Strengths

  • The company benefits from a skilled and experienced leadership team with strong domain knowledge and industry insight.
  • A broad and varied customer base reduces dependency on any single client or market segment.
  • The product portfolio includes a wide range of offerings catering to different aesthetic and dermatological needs.
  • Nationwide presence established through a robust network of consignment sales partners across multiple regions in India.

Peer Group Comparison

As per the DRHP, there are no comparable listed peer of the company and therefore information related to peer is not provided

How to apply IPO with HDFC SKY?

Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.

1Login to your HDFC SKY Account

2Select Issue

3Enter Number of Lots and your Price.

4Enter UPI ID

5Complete Transaction on Your UPI App

Learn More About IPO

FAQs On Aakaar Medical Technologies Limited IPO

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy